How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like 50+ Valeant Sales Reps May Have Jumped Ship to Synergy Pharma February 23, 2017 Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M November 15, 2017 Imprimis Announces First Quarter 2017 Financial Results May 10, 2017
